Order Article Reprints

Veliz EA, Kaplina A, Hettiarachchi SD, Yoham AL, Matta C, Safar S, Sankaran M, Abadi EL, Cilingir EK, Vallejo FA, et al. Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon Dots as Nanocarrier. Pharmaceutics. 2022; 14(7):1465. https://doi.org/10.3390/pharmaceutics14071465

Veliz, Eduardo A., Anastasiia Kaplina, Sajini D. Hettiarachchi, Athina L. Yoham, Carolina Matta, Sabrin Safar, Meghana Sankaran, Esther L. Abadi, Emel Kirbas Cilingir, Frederic A. Vallejo, and et al. 2022. "Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon Dots as Nanocarrier" Pharmaceutics 14, no. 7: 1465. https://doi.org/10.3390/pharmaceutics14071465

Veliz, E. A., Kaplina, A., Hettiarachchi, S. D., Yoham, A. L., Matta, C., Safar, S., Sankaran, M., Abadi, E. L., Cilingir, E. K., Vallejo, F. A., Walters, W. M., Vanni, S., Leblanc, R. M., & Graham, R. M. (2022). Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon Dots as Nanocarrier. Pharmaceutics, 14(7), 1465. https://doi.org/10.3390/pharmaceutics14071465